DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 08 2021
Historique:
received: 31 03 2021
accepted: 02 08 2021
entrez: 19 8 2021
pubmed: 20 8 2021
medline: 11 11 2021
Statut: epublish

Résumé

The comet assay or single cell gel electrophoresis, is the most common method used to measure strand breaks and a variety of other DNA lesions in human populations. To estimate the risk of overall mortality, mortality by cause, and cancer incidence associated to DNA damage, a cohort of 2,403 healthy individuals (25,978 person-years) screened in 16 laboratories using the comet assay between 1996 and 2016 was followed-up. Kaplan-Meier analysis indicated a worse overall survival in the medium and high tertile of DNA damage (p < 0.001). The effect of DNA damage on survival was modelled according to Cox proportional hazard regression model. The adjusted hazard ratio (HR) was 1.42 (1.06-1.90) for overall mortality, and 1.94 (1.04-3.59) for diseases of the circulatory system in subjects with the highest tertile of DNA damage. The findings of this study provide epidemiological evidence encouraging the implementation of the comet assay in preventive strategies for non-communicable diseases.

Identifiants

pubmed: 34408182
doi: 10.1038/s41598-021-95976-7
pii: 10.1038/s41598-021-95976-7
pmc: PMC8373872
doi:

Substances chimiques

Cell-Free Nucleic Acids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16793

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Investigateurs

Diana Anderson (D)
Vanessa Andrade (V)
Cristiana Costa Pereira (CC)
Solange Costa (S)
Kristine B Gutzkow (KB)
Carina Ladeira (C)
Massimo Moretti (M)
Carla Costa (C)
Irene Orlow (I)
Emilio Rojas (E)
Bertrand Pourrut (B)
Marcin Kruszewski (M)
Siegfried Knasmueller (S)
Sergey Shaposhnikov (S)
Bojana Žegura (B)
Helga Stopper (H)

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. The Author(s).

Références

Atherosclerosis. 2013 Oct;230(2):202-9
pubmed: 24075745
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):301-11
pubmed: 7655323
Mutat Res Rev Mutat Res. 2021 Jan-Jun;787:108371
pubmed: 34083035
Mutat Res. 2002 Jun 27;518(1):9-20
pubmed: 12063063
Clin Immunol. 2019 Jun;203:28-36
pubmed: 30930144
Mutat Res Genet Toxicol Environ Mutagen. 2019 Jul;843:90-94
pubmed: 31421744
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Carcinogenesis. 2015 Jun;36 Suppl 1:S61-88
pubmed: 26106144
Mutat Res Rev Mutat Res. 2020 Jan - Mar;783:108288
pubmed: 32192646
Cancer Res. 2004 Mar 15;64(6):2258-63
pubmed: 15026371
Carcinogenesis. 2007 Mar;28(3):625-31
pubmed: 16973674
Mutat Res Rev Mutat Res. 2014 Jan-Mar;759:27-39
pubmed: 24184488
J Crohns Colitis. 2016 Nov;10(11):1316-1323
pubmed: 27095753
Carcinogenesis. 2008 Jun;29(6):1178-83
pubmed: 18356148
Cancer Res. 2000 Mar 15;60(6):1619-25
pubmed: 10749131
Mutagenesis. 2010 Mar;25(2):113-23
pubmed: 19910383
Mutagenesis. 2012 Jul;27(4):385-6
pubmed: 22564849
Environ Mol Mutagen. 2015 Apr;56(3):301-12
pubmed: 25234591
Arch Toxicol. 2013 Jun;87(6):949-68
pubmed: 23685795
Mutat Res Genet Toxicol Environ Mutagen. 2019 Jul;843:95-110
pubmed: 31421745
Cancer Res. 1998 Sep 15;58(18):4117-21
pubmed: 9751622
Am J Epidemiol. 2007 Jan 1;165(1):36-43
pubmed: 17071846
Mutat Res. 2015 Jun;776:118-27
pubmed: 26255943
N Engl J Med. 2009 Oct 8;361(15):1475-85
pubmed: 19812404
Environ Health Perspect. 2005 May;113(5):517-20
pubmed: 15866756
Cancer Res. 2005 Sep 1;65(17):8042-8
pubmed: 16140979
Physiol Res. 2019 Mar 6;68(1):1-15
pubmed: 30433808
Int J Mol Sci. 2018 Mar 23;19(4):
pubmed: 29570697
Mutat Res Genet Toxicol Environ Mutagen. 2019 Jul;843:111-117
pubmed: 31421732
Toxicology. 2017 Sep 1;390:160-166
pubmed: 28928033
Mutat Res Genet Toxicol Environ Mutagen. 2019 Jul;843:81-89
pubmed: 31421743
Mutagenesis. 2020 Feb 13;35(1):5-18
pubmed: 31294794
Radiat Res. 1990 Apr;122(1):86-94
pubmed: 2320728
Nat Protoc. 2020 Dec;15(12):3817-3826
pubmed: 33106678
Cardiovasc Res. 2006 Jul 15;71(2):259-68
pubmed: 16580654
Circulation. 2017 Jun 13;135(24):2369-2372
pubmed: 28606949

Auteurs

Stefano Bonassi (S)

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Rome, Italy. stefano.bonassi@sanraffaele.it.
Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Via di Val Cannuta, 247, 00166, Rome, Italy. stefano.bonassi@sanraffaele.it.

Marcello Ceppi (M)

Clinical Epidemiology Unit, San Martino Policlinic Hospital, Genoa, Italy.

Peter Møller (P)

Department of Public Health, Section of Environmental Health, University of Copenhagen, Oster Farimagsgade 5A, 1014, Copenhagen, Denmark.

Amaya Azqueta (A)

Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31008, Pamplona, Spain.
C/Irunlarrea 3, IdiSNA, Navarra Institute for Health Research, 31008, Pamplona, Spain.

Mirta Milić (M)

Mutagenesis Unit, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000, Zagreb, Croatia.

Monica Neri (M)

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Rome, Italy.

Gunnar Brunborg (G)

Department of Environmental Health, Section of Molecular Toxicology, Norwegian Institute of Public Health (NIPH), Lovisenberggt 6, 0456, Oslo, Norway.

Roger Godschalk (R)

Department of Pharmacology and Toxicology, School of Nutrition and Translational Research in Metabolism, University of Maastricht, Universiteitssingel 50, 6200 MD, Maastricht, The Netherlands.

Gudrun Koppen (G)

Flemish Institute of Technological Research, Environmental Risk and Health Unit VITO - BIOMo, Mol, Belgium.

Sabine A S Langie (SAS)

Department of Pharmacology and Toxicology, School of Nutrition and Translational Research in Metabolism, University of Maastricht, Universiteitssingel 50, 6200 MD, Maastricht, The Netherlands.

João Paulo Teixeira (JP)

Environmental Health Department, National Institute of Health, Rua Alexandre Herculano, 321, 4000-055, Porto, Portugal.
Environmental Health Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Rua Alexandre Herculano 321, 4000-055, Porto, Portugal.
EPIUnit - Instituto de Saúde Pública, Universidade Do Porto, Rua das Taipas, no 135, 4050-600, Porto, Portugal.

Marco Bruzzone (M)

Clinical Epidemiology Unit, San Martino Policlinic Hospital, Genoa, Italy.

Juliana Da Silva (J)

Laboratory of Genetic Toxicology, Lutheran University of Brazil (ULBRA), and La Salle University (UNILASALLE), Canoas, RS, Brazil.

Danieli Benedetti (D)

Laboratory of Genetic Toxicology, Lutheran University of Brazil (ULBRA), and La Salle University (UNILASALLE), Canoas, RS, Brazil.

Delia Cavallo (D)

Department of Occupational and Environmental Medicine, Epidemiology and Hygiene (DiMEILA), Italian Workers' Compensation Authority (INAIL), Via Fontana Candida 1, 00078, Monte Porzio Catone (Rome), Italy.

Cinzia Lucia Ursini (CL)

Department of Occupational and Environmental Medicine, Epidemiology and Hygiene (DiMEILA), Italian Workers' Compensation Authority (INAIL), Via Fontana Candida 1, 00078, Monte Porzio Catone (Rome), Italy.

Lisa Giovannelli (L)

Department NEUROFARBA, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.

Silvia Moretti (S)

Department of Health Sciences, Division of Dermatology, University of Florence, Palagi Hospital, Viale Michelangelo 41, Florence, Italy.

Patrizia Riso (P)

Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133, Milan, Italy.

Cristian Del Bo' (C)

Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133, Milan, Italy.

Patrizia Russo (P)

Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Rome, Italy.
Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Via di Val Cannuta, 247, 00166, Rome, Italy.

Malgorzata Dobrzyńska (M)

Department of Radiation Hygiene and Radiobiology, National Institute of Public Health NIH - National Research Institute, 24 Chocimska Street, 00-791, Warsaw, Poland.

Irina A Goroshinskaya (IA)

Laboratory for the Study of the Pathogenesis of Malignant Tumors, National Medical Research Center for Oncology, 14 line 63, 344037, Rostov-on-Don, Russia.

Ekaterina I Surikova (EI)

Laboratory for the Study of the Pathogenesis of Malignant Tumors, National Medical Research Center for Oncology, 14 line 63, 344037, Rostov-on-Don, Russia.

Marta Staruchova (M)

Institute of Biology, Medical Faculty, Slovak Medical University, Limbova 12, 83303, Bratislava, Slovakia.

Magdalena Barančokova (M)

Institute of Biology, Medical Faculty, Slovak Medical University, Limbova 12, 83303, Bratislava, Slovakia.

Katarina Volkovova (K)

Institute of Biology, Medical Faculty, Slovak Medical University, Limbova 12, 83303, Bratislava, Slovakia.

Alena Kažimirova (A)

Institute of Biology, Medical Faculty, Slovak Medical University, Limbova 12, 83303, Bratislava, Slovakia.

Bozena Smolkova (B)

Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, Bratislava, Slovakia.

Blanca Laffon (B)

Grupo DICOMOSA, Centro de Investigaciones Científicas Avanzadas (CICA), Departamento de Psicología, Facultad de Ciencias de La Educación, Universidade da Coruña, Campus Elviña s/n, 15071, A Coruña, Spain.
Instituto de Investigación Biomédica de A Coruña (INIBIC), AE CICA-INIBIC, Oza, 15071, A Coruña, Spain.

Vanessa Valdiglesias (V)

Instituto de Investigación Biomédica de A Coruña (INIBIC), AE CICA-INIBIC, Oza, 15071, A Coruña, Spain.
Grupo DICOMOSA, Centro de Investigaciones Científicas Avanzadas (CICA), Departamento de Biología, Facultad de Ciencias, Universidade da Coruña, Campus A Zapateira s/n, 15071, A Coruña, Spain.

Susana Pastor (S)

Department of Genetics and Microbiology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès (Barcelona), Spain.

Ricard Marcos (R)

Department of Genetics and Microbiology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès (Barcelona), Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, 28029, Madrid, Spain.

Alba Hernández (A)

Department of Genetics and Microbiology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193, Cerdanyola del Vallès (Barcelona), Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Carlos III Institute of Health, 28029, Madrid, Spain.

Goran Gajski (G)

Mutagenesis Unit, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000, Zagreb, Croatia.

Biljana Spremo-Potparević (B)

Center of Biological Research, Faculty of Pharmacy, University of Belgrade, VojvodeStepe 450, Belgrade, Serbia.

Lada Živković (L)

Center of Biological Research, Faculty of Pharmacy, University of Belgrade, VojvodeStepe 450, Belgrade, Serbia.

Elisa Boutet-Robinet (E)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France.

Hervé Perdry (H)

Univ Paris-Saclay, CESP, Villejuif, France.

Pierre Lebailly (P)

ANTICIPE Unit, INSERM & University of Caen-Normandie Centre François Baclesse, Avenue du Général Harris, 14076, Caen Cedex 05, France.

Carlos L Perez (CL)

Department of Biochemistry, Instituto de Ciencias Básicas Y Preclínicas "Victoria de Giron", Universidad de Ciencias Médicas de La Habana, 146 St. and 31 Ave, No, 3102, Playa, Habana, Cuba.

Nursen Basaran (N)

Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.

Zsuzsanna Nemeth (Z)

Department of Non-Ionizing Radiation, National Public Health Center, Anna Street 5, 1221, Budapest, Hungary.

Anna Safar (A)

Department of Non-Ionizing Radiation, National Public Health Center, Anna Street 5, 1221, Budapest, Hungary.

Maria Dusinska (M)

NILU, Health Effects Laboratory, Kjeller, Norway.

Andrew Collins (A)

Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH